Supplementary Table 1: Cutaneous adverse events associated with MEK-inhibitors for the treatment of vascular anomalies: a multicenter retrospective study

Name: Supplementary Table 1: Cutaneous adverse events associated with MEK-inhibitors for the treatment of vascular anomalies: a multicenter retrospective study
Creator: Isabella Plumptre
Published: 2025-10-27T09:30:35.427Z
Keywords: Dermatology, Vascular Malformation, Pediatric Oncology, Pediatric Hematology

Plumptre, Isabella; Bitar, Racquel; Grenier, Pierre-Olivier; Lee, Yeji; Shah, Tishi; Stockton Hogrogian, Griffin; Yan, Albert; Argade, Shivangi; Casey, Melissa; Santos, Samantha; Treat, James; Liang, Marilyn

doi:10.17632/zncp6xz9zw.3

Supplementary Table 1: Cutaneous adverse events associated with MEK-inhibitors for the treatment of vascular anomalies: a multicenter retrospective study

Published: 27 October 2025| Version 3 | DOI: 10.17632/zncp6xz9zw.3

Contributors:

Isabella Plumptre, Racquel Bitar, Pierre-Olivier Grenier, Yeji Lee, Tishi Shah, Griffin Stockton Hogrogian, Albert Yan, Shivangi Argade, Melissa Casey, Samantha Santos, James Treat, Marilyn Liang

Description

Supplementary Table 1: Most common cutaneous adverse events observed in patients with vascular anomalies taking MEK-inhibitors, excluding patients on concurrent therapies.

Supplementary Table 1: Cutaneous adverse events associated with MEK-inhibitors for the treatment of vascular anomalies: a multicenter retrospective study

Description

Files

Categories

Licence